Integral Health Asset Management’s Amedisys AMED Stock Holding History

Integral Health Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,000	Closed	-$3.19M	–	64
2022 Q3	$3.19M	Buy	+33,000	New	+$3.94M	0.62%	55
2022 Q2	–	Sell	-40,000	Closed	-$6.89M	–	67
2022 Q1	$6.89M	Sell	40,000 -10,000	-20%	-$1.49M	1.79%	19
2021 Q4	$8.09M	Buy	+50,000	New	+$8.04M	2.24%	14
2020 Q1	–	Sell	-65,000	Closed	-$10.8M	–	54
2019 Q4	$10.8M	Buy	+65,000	New	+$9.67M	4.22%	5

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Integral Health Asset Management's AMED Position: Q4 2022 in Review

Integral Health Asset Management sold out of Amedisys (AMED) in Q4 2022, closing a stake of 33,000 shares — an estimated $3.19M sold.

Integral Health Asset Management first reported a position in AMED in Q4 2019 and held it in 4 quarters. The position peaked at $10.8M in Q4 2019. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

Integral Health Asset Management reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
Integral Health Asset Management sold 33,000 Amedisys shares in Q4 2022, an estimated $3.19M.
Integral Health Asset Management first reported a position in Amedisys in Q4 2019 and held it in 4 quarters.
Integral Health Asset Management's Amedisys position peaked at $10.8M in Q4 2019.
277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.